A multicenter, prospective randomized controlled modified dual platform trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers (TIGERCAMP). ijtr [Internet]. 2025 Oct. 31 [cited 2025 Dec. 12];1(Suppl 2). Available from: https://www.internationaljournaloftissuerepair.com/index.php/ijtr/article/view/53